文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

慢性腹膜透析患者的骨矿物质密度及其与临床和实验室因素的相关性。

Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.

作者信息

Ersoy Fettah Fevzi, Passadakis Stauros Ploumis, Tam Paul, Memmos Evaggelos Dimitros, Katopodis Pericles Konstantinos, Ozener Cetin, Akçiçek Fehmi, Camsari Taner, Ateş Kenan, Ataman Rezzan, Vlachojannis John George, Dombros Athanasios Nicholas, Utaş Cengiz, Akpolat Tekin, Bozfakioğlu Semra, Wu George, Karayaylali Ibrahim, Arinsoy Turgay, Stathakis Panagiotis Charalampos, Yavuz Mahmut, Tsakiris John Dimitrios, Dimitriades Chrysostomos Athanasios, Yilmaz Mehmet Emin, Gültekin Meral, Karayalçin Binnur, Yardimsever Mehmet, Oreopoulos Dimitrios George

机构信息

Division of Nephrology, Department of Medicine, Akdeniz University Medical School, 07070 Dumlupinar Bulvari, Kampus, Antalya, Turkey.

出版信息

J Bone Miner Metab. 2006;24(1):79-86. doi: 10.1007/s00774-005-0650-3.


DOI:10.1007/s00774-005-0650-3
PMID:16369903
Abstract

The aim of this study was to assess the clinical and laboratory correlations of bone mineral density (BMD) measurements among a large population of patients on chronic peritoneal dialysis (PD). This cross-sectional, multicenter study was carried out in 292 PD patients with a mean age of 56 +/- 16 years and mean duration of PD 3.1 +/- 2.1 years. Altogether, 129 female and 163 male patients from 24 centers in Canada, Greece, and Turkey were included in the study. BMD findings, obtained by dual-energy X-ray absorptiometry (DEXA) and some other major clinical and laboratory indices of bone mineral deposition as well as uremic osteodystrophy were investigated. In the 292 patients included in the study, the mean lumbar spine T-score was -1.04 +/- 1.68, the lumbar spine Z-score was -0.31 +/- 1.68, the femoral neck T-score was -1.38 +/- 1.39, and the femoral neck Z score was -0.66 +/- 1.23. According to the WHO criteria based on lumbar spine T-scores, 19.2% of 292 patients were osteoporotic, 36.3% had osteopenia, and 44.4% had lumbar spine T-scores within the normal range. In the femoral neck area, the prevalence of osteoporosis was slightly higher (26%). The prevalence of osteoporosis was 23.3% in female patients and 16.6% in male patients with no statistically significant difference between the sexes. Agreements of lumbar spine and femoral neck T-scores for the diagnosis of osteoporosis were 66.7% and 27.3% and 83.3% for osteopenia and normal BMD values, respectively. Among the clinical and laboratory parameters we investigated in this study, the body mass index (BMI) (P < 0.001), daily urine output, and urea clearance time x dialysis time/volume (Kt/V) (P < 0.05) were statistically significantly positive and Ca x PO(4) had a negative correlation (P < 0.05) with the lumbar spine T scores. Femoral neck T scores were also positively correlated with BMI, daily urine output, and KT/V; and they were negatively correlated with age. Intact parathyroid hormone levels did not correlate with any of the BMD parameters. Femoral neck Z scores were correlated with BMI (P < 0.001), and ionized calcium (P < 0.05) positively and negatively with age, total alkaline phosphatase (P < 0.05), and Ca x P (P < 0.01). The overall prevalence of fractures since the initiation of PD was 10%. Our results indicated that, considering their DEXA-based BMD values, 55% of chronic PD patients have subnormal bone mass-19% within the osteoporotic range and 36% within the osteopenic range. Our findings also indicate that low body weight is the most important risk factor for osteoporosis in chronic PD patients. An insufficient dialysis dose (expressed as KT/V) and older age may also be important risk factors for osteoporosis of PD patients.

摘要

本研究旨在评估大量慢性腹膜透析(PD)患者骨矿物质密度(BMD)测量值与临床及实验室指标之间的相关性。这项横断面多中心研究纳入了292例PD患者,其平均年龄为56±16岁,平均PD病程为3.1±2.1年。该研究共纳入了来自加拿大、希腊和土耳其24个中心的129例女性患者和163例男性患者。研究调查了通过双能X线吸收法(DEXA)获得的BMD结果,以及骨矿物质沉积和肾性骨营养不良的其他一些主要临床和实验室指标。在纳入研究的292例患者中,腰椎T值平均为-1.04±1.68,腰椎Z值为-0.31±1.68,股骨颈T值为-1.38±1.39,股骨颈Z值为-0.66±1.23。根据基于腰椎T值的世界卫生组织标准,292例患者中19.2%为骨质疏松症患者,36.3%为骨量减少患者,44.4%的腰椎T值在正常范围内。在股骨颈区域,骨质疏松症的患病率略高(26%)。女性患者骨质疏松症患病率为23.3%,男性患者为16.6%,两性之间无统计学显著差异。腰椎和股骨颈T值诊断骨质疏松症的一致性分别为66.7%,诊断骨量减少和正常BMD值的一致性分别为27.3%和83.3%。在本研究中调查的临床和实验室参数中,体重指数(BMI)(P<0.001)、每日尿量以及尿素清除时间×透析时间/容积(Kt/V)(P<0.05)与腰椎T值呈统计学显著正相关,而钙×磷(Ca×PO₄)与腰椎T值呈负相关(P<0.05)。股骨颈T值也与BMI、每日尿量和Kt/V呈正相关;与年龄呈负相关。完整甲状旁腺激素水平与任何BMD参数均无相关性。股骨颈Z值与BMI(P<0.001)呈正相关,与离子钙呈正相关(P<0.05),与年龄、总碱性磷酸酶(P<0.05)和钙×磷(Ca×P)(P<0.01)呈负相关。自开始PD治疗以来骨折的总体患病率为10%。我们的结果表明,根据基于DEXA的BMD值,55%的慢性PD患者骨量低于正常水平,其中19%处于骨质疏松范围内,36%处于骨量减少范围内。我们的研究结果还表明,低体重是慢性PD患者骨质疏松症的最重要危险因素。透析剂量不足(以Kt/V表示)和年龄较大也可能是PD患者骨质疏松症的重要危险因素。

相似文献

[1]
Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.

J Bone Miner Metab. 2006

[2]
Nutritional markers, not markers of bone turnover, are related predictors of bone mineral density in chronic peritoneal dialysis patients.

Clin Nephrol. 2010-11

[3]
Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis.

Perit Dial Int. 2004

[4]
Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.

Arch Osteoporos. 2012-9-1

[5]
Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.

Calcif Tissue Int. 1999-7

[6]
Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.

J Bone Miner Res. 1996-1

[7]
Bone mineral density and related clinical and laboratory factors in peritoneal dialysis patients: Implications for bone health management.

PLoS One. 2024

[8]
Loss of bone mineral density in renal transplantation recipients.

Transplant Proc. 2010-11

[9]
Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients.

Adv Ther. 2007

[10]
Aged-Related Changes in Body Composition and Association between Body Composition with Bone Mass Density by Body Mass Index in Chinese Han Men over 50-year-old.

PLoS One. 2015-6-19

引用本文的文献

[1]
Bone mineral density and related clinical and laboratory factors in peritoneal dialysis patients: Implications for bone health management.

PLoS One. 2024

[2]
Correlation of Fgf23 and Balp with Bone Mineral Density in Hemodialysis Patients.

J Med Biochem. 2019-7-30

[3]
DEVELOPMENT OF CLINICAL RISK ASSESSMENT TOOL FOR OSTEOPOROSIS (OSTEORISKAPP) USING A SYNDROMIC APPROACH.

Acta Endocrinol (Buchar). 2018

[4]
Abdominal aortic calcification score among several vascular calcification scores of plain radiograph is the most reliable predictor of severe coronary artery calcification in dialysis patients.

Ren Fail. 2017-11

[5]
Inverse relationship of bone mineral density and serum level of N-terminal pro-B-type natriuretic peptide in peritoneal dialysis patients.

Tzu Chi Med J. 2016

[6]
Evaluation of fracture risk in chronic kidney disease.

J Nephrol. 2017-4-6

[7]
Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis.

Osteoporos Int. 2016-12

[8]
FGF-23, α-Klotho Gene Polymorphism and Their Relationship with the Markers of Bone Metabolism in Chronic Peritoneal Dialysis Patients.

Eurasian J Med. 2015-6

[9]
Increased risk of cardiovascular events in end-stage renal disease patients with osteoporosis: a nationwide population-based cohort study.

Osteoporos Int. 2015-2

[10]
Determinants of bone mineral density in patients on haemodialysis or peritoneal dialysis--a cross-sectional, longitudinal study.

Biochem Med (Zagreb). 2013

本文引用的文献

[1]
Osteoporosis in chronic kidney disease.

Am J Kidney Dis. 2004-3

[2]
Bone mineral density in elderly Chinese: effects of age, sex, weight, height, and body mass index.

J Bone Miner Metab. 2004

[3]
Pain in hemodialysis patients: prevalence, cause, severity, and management.

Am J Kidney Dis. 2003-12

[4]
Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.

Nephrol Dial Transplant. 2003-11

[5]
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Am J Kidney Dis. 2003-10

[6]
Development of lumbar bone mineral density in the late course after kidney transplantation.

Am J Kidney Dis. 2002-11

[7]
Bone density and heel ultrasound testing do not identify patients with dialysis-dependent renal failure who have had fractures.

Am J Kidney Dis. 2002-4

[8]
Bone mineral density in patients beginning hemodialysis treatment.

Am J Nephrol. 2002

[9]
Bone mass in chronic renal insufficiency patients treated with continuous ambulatory peritoneal dialysis.

Adv Perit Dial. 2001

[10]
A comparison of quantitative computed tomography and dual X-ray absorptiometry for evaluation of bone mineral density in patients on chronic hemodialysis.

Am J Kidney Dis. 2001-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索